AWM
IBB icon

Altavista Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Altavista Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$3.43M Buy
22,454
+1,218
+6% +$189K 0.69% 37
2021
Q3 		$3.43M Sell
21,236
-103
-0.5% -$17.3K 0.76% 35
2021
Q2 		$3.49M Buy
21,339
+1,723
+9% +$265K 0.76% 37
2021
Q1 		$2.95M Sell
19,616
-74
-0.4% -$11.8K 0.72% 37
2020
Q4 		$2.98M Sell
19,690
-146
-0.7% -$20.9K 0.76% 34
2020
Q3 		$2.69M Sell
19,836
-816
-4% -$111K 0.74% 37
2020
Q2 		$2.82M Sell
20,652
-92
-0.4% -$11.7K 0.82% 35
2020
Q1 		$2.23M Buy
20,744
+603
+3% +$69.4K 0.76% 34
2019
Q4 		$2.43M Sell
20,141
-2,763
-12% -$308K 0.72% 38
2019
Q3 		$2.28M Buy
22,904
+481
+2% +$50.4K 0.71% 39
2019
Q2 		$2.45M Buy
22,423
+128
+0.6% +$13.6K 0.78% 36
2019
Q1 		$2.49M Buy
22,295
+171
+0.8% +$18.8K 0.88% 35
2018
Q4 		$2.13M Buy
22,124
+869
+4% +$92.2K 0.87% 38
2018
Q3 		$2.59M Sell
21,255
-132
-0.6% -$15.5K 0.96% 34
2018
Q2 		$2.35M Sell
21,387
-183
-0.8% -$19.6K 0.94% 34
2018
Q1 		$2.3M Buy
21,570
+2,540
+13% +$282K 0.97% 32
2017
Q4 		$2.03M Buy
19,030
+247
+1% +$26.4K 0.86% 38
2017
Q3 		$2.09M Buy
18,783
+429
+2% +$45.9K 0.99% 33
2017
Q2 		$1.9M Buy
18,354
+1,395
+8% +$137K 0.94% 36
2017
Q1 		$1.66M Buy
16,959
+2,922
+21% +$280K 0.83% 39
2016
Q4 		$1.24M Buy
14,037
+1,818
+15% +$165K 0.67% 43
2016
Q3 		$1.18M Buy
+12,219
New +$1.16M 0.64% 43

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Altavista Wealth Management's IBB Position: Q4 2021 in Review

Altavista Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 5.7% in Q4 2021, buying an estimated $189K and bringing the position to 22,454 shares worth $3.43M. The position accounts for 0.69% of the portfolio, ranked #37.

Altavista Wealth Management first reported a position in IBB in Q3 2016 and has held it in 22 quarters since. The position peaked at $3.49M in Q2 2021. 963 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

  • Altavista Wealth Management held 22,454 shares of iShares Biotechnology ETF worth $3.43M as of Q4 2021.
  • Altavista Wealth Management bought 1,218 iShares Biotechnology ETF shares in Q4 2021, an estimated $189K.
  • iShares Biotechnology ETF made up 0.69% of Altavista Wealth Management's portfolio in Q4 2021, its #37 holding.
  • Altavista Wealth Management first reported a position in iShares Biotechnology ETF in Q3 2016 and has held it in 22 quarters since.
  • Altavista Wealth Management's iShares Biotechnology ETF position peaked at $3.49M in Q2 2021.
  • 963 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on Altavista Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.